Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

NCT01514500 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01514500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01514500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
January 16, 2012
Completion date
March 18, 2013
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult growth hormone deficiency, growth hormone deficiency in children, growth hormone disorder, healthy